EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Control of canine idiopathic nasal hyperkeratosis with a natural skin restorative balm: a randomized double-blind placebo-controlled study



Control of canine idiopathic nasal hyperkeratosis with a natural skin restorative balm: a randomized double-blind placebo-controlled study



Veterinary Dermatology 29(2): 134-E53



Nasal hyperkeratosis may cause discomfort in dogs by predisposing them to fissures and secondary bacterial infection. Approaches to treatment have been described anecdotally; the effectiveness of such therapies remains unproven. To investigate the efficacy of a balm containing essential oils and essential fatty acids in dogs with idiopathic nasal hyperkeratosis. Client-owned dogs with noncomplicated nasal hyperkeratosis. The study was conducted as a randomized, double-blind, placebo-controlled clinical trial with parallel group design and two month follow-up period. Dogs received daily topical application of a commercial balm product (group DBB) or placebo (aqueous gelling agent with preservatives, group PB). The main outcome variables were lichenification, dryness, suppleness and extent of lesions. Subjective owner satisfaction index score was a secondary variable. Evaluation was performed on days (D)0, 30 and 60. Response to treatment was assessed as the change from baseline to each examination day for each criterion. Forty eight dogs, principally French (26 of 48) and English (seven of 48) bulldogs, were included and 39 completed the study. No major adverse events were reported. On D60, changes from baseline for lichenification, lesion extent, suppleness and total score were -31.2%, -18.3%, -72.8% and -36.8% in group DBB (23 dogs) and -11.9%, 2.3%, -42.1% and -14% in group PB (16 dogs), respectively. The total score was significantly improved on D60 in group DBB compared to PB (Wilcoxon-Mann-Whitney U-test, P = 0.0016). The balm proved safe and helpful in managing canine idiopathic noncomplicated nasal hyperkeratosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 059549349

Download citation: RISBibTeXText

PMID: 29076573

DOI: 10.1111/vde.12506



Related references

Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 23(1): 49-58, 1985

The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Oto-Laryngologica 126(6): 606-612, 2006

The change in nasal inflammatory markers after intranasal challenges with particulate chitin and lipopolysaccharide: a randomized, double-blind, placebo-controlled, crossover study with a positive control. International Forum of Allergy & Rhinology 5(8): 716-723, 2016

Flunisolide nasal spray 0.025 percent in the prophylactic treatment of nasal polyposis after polypectomy a randomized double blind parallel placebo controlled study. Rhinology (Utrecht) 23(1): 49-58, 1985

Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia-A randomized double-blind placebo-controlled clinical trial. Complementary Therapies in Medicine 26(): 136-140, 2016

Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study. Laryngoscope 125(9): 2041-2045, 2015

Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. British Journal of Dermatology 154(3): 533-538, 2006

Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 46(2): 212-222, 2006

A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis. International Journal of Pediatric Otorhinolaryngology 39(1): 1-8, 1997

A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency. American Journal of Rhinology 22(3): 276-279, 2008

Acupuncture for nasal congestion: a prospective, randomized, double-blind, placebo-controlled clinical pilot study. American Journal of Rhinology & Allergy 23(6): E23-E28, 2010

Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Archives of Internal Medicine 154(22): 2567-2572, 1994

The lack of effectiveness of kallikrein in the treatment of idiopathic oligozoospermia: A double-blind, randomized, placebo-controlled study. Japanese Journal of Fertility & Sterility 41(2): 129-134, 1996

Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisone. Laryngoscope 103(12): 1326-1333, 1993

Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Allergy 62(5): 539-546, 2007